Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05117034 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 20, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Dec 1, 2023 to May 1, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  2. Primary completion date: Dec 2022 to Dec 1, 2023
    • Study completion date: Mar 2023 to Dec 1, 2023
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2021 to Feb 16, 2022
    v3
  4. Start date: Nov 2021 to Dec 2021v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We propose a double-blind randomized controlled trial to evaluate the effect of intravenously administered morphine at surgery conclusion on acute postoperative pain in patients recovering from craniotomy surgery. Participating adults having craniotomy surgery will be randomized in a 1:1 ratio to intraoperative intravenous administration of 0.08 mg/kg morphine at dura closure, or a matching placebo.
Trial Details
NCT Number NCT05117034
Lead Sponsor Tel-Aviv Sourasky Medical Center
Conditions
(from sponsor)		 Pain, Postoperative, Anesthesia, Analgesia
Related terms Agnosia, Postoperative Pain
Enrollment 115 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov